within Pharmacolibrary.Drugs.ATC.G;

model G03FA15
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.91,
    Cl             = 5.833333333333333e-05,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.046,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.025,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03FA15</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dienogest and estrogen combination is used as an oral contraceptive to prevent pregnancy. It can also be used in the management of endometriosis and other gynecological disorders. These drugs work by inhibiting ovulation and altering the cervical mucus and endometrium. Currently, dienogest in combination with estrogens is approved and commonly used in various countries as part of combined oral contraceptive (COC) therapy.</p><h4>Pharmacokinetics</h4><p>Estimate for healthy adult women using combined oral contraceptive tablets containing dienogest 2 mg and ethinylestradiol 0.03 mg, administered orally.</p><h4>References</h4><ol><li><p>Stanczyk, FZ, et al., &amp; Archer, DF (2024). Comparison of estrogenic components used for hormonal contraception. <i>Contraception</i> 130 110310–None. DOI:<a href=&quot;https://doi.org/10.1016/j.contraception.2023.110310&quot;>10.1016/j.contraception.2023.110310</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37863464/&quot;>https://pubmed.ncbi.nlm.nih.gov/37863464</a></p></li><li><p>Wellington, K, &amp; Perry, CM (2002). Estradiol valerate/dienogest. <i>Drugs</i> 62(3) 491–506. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200262030-00006&quot;>10.2165/00003495-200262030-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11827562/&quot;>https://pubmed.ncbi.nlm.nih.gov/11827562</a></p></li><li><p>Zeun, S, et al., &amp; Blode, H (2009). Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest. <i>The European journal of contraception &amp; reproductive health care : the official journal of the European Society of Contraception</i> 14(3) 221–232. DOI:<a href=&quot;https://doi.org/10.1080/13625180902850039&quot;>10.1080/13625180902850039</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19565420/&quot;>https://pubmed.ncbi.nlm.nih.gov/19565420</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03FA15;
